Generation Bio Co.

NASDAQ: GBIO · Real-Time Price · USD
6.40
-0.26 (-3.90%)
At close: Aug 15, 2025, 10:08 AM
-3.90%
Bid 4.53
Market Cap 43.1M
Revenue (ttm) 24.56M
Net Income (ttm) -71.93M
EPS (ttm) -10.84
PE Ratio (ttm) -0.59
Forward PE -0.37
Analyst Hold
Ask 8.06
Volume 30,203
Avg. Volume (20D) 348,194
Open 6.49
Previous Close 6.66
Day's Range 6.28 - 6.51
52-Week Range 3.00 - 29.40
Beta 2.67

About GBIO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GBIO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Generation Bio has released their quartely earnings on Aug 12, 2025:
  • Revenue of $765K misses estimates by $1.37M, with -81.30% YoY decline.
  • EPS of -3.12 misses estimates by -0.50, with -906.45% YoY decline.
  • Next Earnings Release

    Generation Bio Co. is scheduled to release its earnings on Nov 5, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 days ago
    +63.21%
    Generation Bio shares are trading higher after the... Unlock content with Pro Subscription
    2 days ago
    +0.25%
    Generation Bio shares are trading higher after the company announced new data demonstrating that its cell-targeted lipid nanoparticle system selectively delivered siRNA to T cells in non-human primates.